Association of Interferon-alpha and bone density in patients with hepatitis C

Background: Chronic hepatitis is a variety of liver dysfunctions with different causes and severities in which inflammation and necrosis last for at least six months. Choice treatment for all chronic viral hepatitis is interferon Alpha (IFN-α). Decreasing bone mass density (BMD) may lead t...

Full description

Bibliographic Details
Main Authors: Abbas Arj, Kamal Esalatmanesh, Seyed AliReza Moravveji, Shahrzad Karimi, Eman Ghaffarpasand
Format: Article
Language:English
Published: Bushehr University of Medical Sciences 2014-11-01
Series:Iranian South Medical Journal
Subjects:
Online Access:http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-512&slc_lang=en&sid=1